Anonymous
Guest
Anonymous
Guest
PROUD ABT!! Abbott Is Undervalued With Significant Prospects In Vision Care
Jun. 26, 2014 4:54 PM ET | About: Abbott Laboratories (ABT), Includes: JNJ, NVS
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary
Abbott received CE Marking for its implantable Tecnis lenses in Europe.
WHO says that global annual target for cataract surgeries should be 32 million by 2020.
The global vision care devices market will reach $46 billion by 2017, representing significant opportunities for Abbott.
Jun. 26, 2014 4:54 PM ET | About: Abbott Laboratories (ABT), Includes: JNJ, NVS
Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)
Summary
Abbott received CE Marking for its implantable Tecnis lenses in Europe.
WHO says that global annual target for cataract surgeries should be 32 million by 2020.
The global vision care devices market will reach $46 billion by 2017, representing significant opportunities for Abbott.